Science Explorer Back to mapMap
Discussion
Researcher · Tenovus Cancer Care · United Kingdom

Robert I. Nicholson

Robert I. Nicholson publishes mostly in Oncology, Genetics and Molecular Biology, on topics such as Estrogen and related hormone effects, HER2/EGFR in Cancer Research and Breast Cancer Treatment Studies.

OpenAlex
World rank
#151,370
of 7,710,434 ranked researchers
Rank in United Kingdom
#13,662
of 367,258
Works
376
Citations
24k
Citations per work
63.7
h-index
84
i10-index 220Top 0.7% in Oncology
Robert I. Nicholson

What does Robert I. Nicholson research?

Robert I. Nicholson's work is mostly in Biochemistry, Genetics and Molecular Biology (44%), Medicine (26%).

Life Sciences: 165 works · 43.8% of their workBiochemistry, Genetics and Molecular Biology: 165 works · 43.8% of their workGenetics: 71 works · 19.0% of their workMolecular Biology: 68 works · 18.2% of their workCancer Research: 25 works · 6.6% of their workEverything else: 114 works · 30.4% of their workHealth Sciences: 97 works · 25.8% of their workMedicine: 97 works · 25.8% of their workOncology: 76 works · 20.2% of their workPulmonary and Respiratory Medicine: 11 works · 3.0% of their workEndocrinology, Diabetes and Metabolism: 10 works · 2.6% of their workTHEIR WORKRobert I.Nicholson376works
Life Sciences44%Health Sciences26%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology16543.8%
  2. Everything else11430.4%
    1. Medicine9725.8%
  1. 1Oncology20% of their works
  2. 2Genetics19% of their works
  3. 3Molecular Biology18% of their works
  4. 4Cancer Research7% of their works
  5. 5Pulmonary and Respiratory Medicine3% of their works
  6. 6Endocrinology, Diabetes and Metabolism3% of their works

Research topics

Which keywords describe Robert I. Nicholson's research?

The keywords of their largest research topics: Breast Cancer, Signaling, Transcriptional Regulation, Estrogen, Receptor, HER2, Trastuzumab and Cancer.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Breast Cancer2462 topics
  2. Signaling1772 topics
  3. Transcriptional Regulation1752 topics
  4. Estrogen1591 topic
  5. Receptor1591 topic
  6. HER2871 topic
  7. Trastuzumab871 topic
  8. Cancer382 topics
  9. Metabolism382 topics
  10. Breast Tumours371 topic
  11. Gene Expression371 topic
  12. Cancer Stem Cells261 topic
  13. Tumor Metastasis261 topic
  14. IGF-1201 topic
  15. Insulin-like Growth Factors201 topic
  16. Fc Receptors191 topic
  17. Therapeutic Antibodies191 topic
  18. PI3K/AKT pathway181 topic
  19. mTOR181 topic
  20. Protein Kinases161 topic
  21. Ras Signaling161 topic

Where does Robert I. Nicholson work?

Robert I. Nicholson's main affiliation in the publication record is Tenovus Cancer Care, United Kingdom.

How many publications and citations does Robert I. Nicholson have?

OpenAlex counts 376 works and 23,942 citations for Robert I. Nicholson, an h-index of 84, ranking #151,370 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Robert I. Nicholson. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.